Comparing Astragalus Plus Gemcitabine to Gemcitabine Alone as Neoadjuvant Treatment for Pancreatic Cancer Patients
Conditions: Pancreatic Cancer Interventions: Drug: Astragalus + Gemcitabine; Drug: Gemcitabine alone Sponsors: Shenzhen University General Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Astragalus | Cancer | Cancer & Oncology | Hospitals | Neoadjuvant Therapy | Pancreas | Pancreatic Cancer | Research